Skip to main content
. 2022 Dec 29;28(1):290. doi: 10.3390/molecules28010290

Figure 6.

Figure 6

Fate of pro-inflammatory markers in experimental animals after co-treatment with EFD (05 and 10 mg/kg). (NO) Nitric oxide, (TBARS) Thiobarbituric acid reducing substances (Lipid peroxidation assay), (IL-6) Interleukin-6, (TNF-α) Tumor necrosis factor alpha. Data is presented as mean ± SD (n = 7). Differences in serum levels were considered significant at the level of ** p < 0.05 and *** p < 0.01.